Occupancy of the kappa opioid receptor predicts reduction in drinking after naltrexone

被引：0
|
作者：
de Laat, B. [1 ]
Goldberg, A. [2 ]
Nabulsi, N. [1 ]
Huang, Y. [1 ]
O'Malley, S. S. [2 ]
Morris, E. D. [1 ,2 ,3 ]
Krishnan-Sarin, S. [2 ]
机构：
[1] Yale Sch Med, Dept Radiol, New Haven, CT USA
[2] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
[3] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PA00-A45
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [21] THE kappa-opioid receptor in the nucleus accumbens shell: Factors in the effects on ethanol drinking
    Pirino, B. E.
    Carpenter, B. A.
    Candelas, P. G.
    Hawks, A.
    Curtis, G. R.
    Gargiulo, A. T.
    Karkhanis, A. N.
    Barson, J. R.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 375 - 375
  • [22] EFFECT OF CHRONIC ADMINISTRATION OF NALTREXONE ON BRAIN MU-OPIOID AND KAPPA-OPIOID RECEPTORS AND RESPONSES TO U-50,488H, A KAPPA-OPIOID RECEPTOR AGONIST IN THE MOUSE
    VILLAR, VM
    RAHMANI, NH
    BHARGAVA, HN
    FASEB JOURNAL, 1995, 9 (03): : A102 - A102
  • [23] NALTREXONE AND NALMEFENE ARE G-PROTEIN BIASED PARTIAL AGONISTS OF THE KAPPA OPIOID RECEPTOR: IN VITRO AND IN VIVO EXAMINATION
    Windisch, K. A.
    Reed, B.
    Dunn, A.
    Guariglia, C.
    Kreek, M. J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 141A - 141A
  • [24] Evaluation of Kappa and Mu Opioid Receptor Occupancy by CVL-354 Using PET in Nonhuman Primates
    Duvvuri, Sridhar
    Iredale, Philip
    Suidan, Georgette
    Chakilam, Srinivas
    Gokulrangan, Giri
    Nabulsi, Nabeel
    Huang, Yiyun
    Holden, Daniel
    Carson, Richard
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 479 - 479
  • [25] PHARMACOGENETICS OF NALTREXONE: BEYOND THE MU OPIOID RECEPTOR
    Bujarski, S.
    Courtney, K. E.
    Ray, L. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 246A - 246A
  • [26] A review of the kappa opioid receptor system in opioid use
    Cayir, Salih
    Zhornitsky, Simon
    Barzegary, Alireza
    Sotomayor-Carreno, Esteban
    Sarfo-Ansah, Wonder
    Funaro, Melissa C.
    Matuskey, David
    Angarita, Gustavo
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2024, 162
  • [27] Novel opioid peptides as kappa opioid receptor antagonists
    Aldrich, JV
    Wan, Q
    Murray, TF
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 616 - 618
  • [28] Kappa-opioid receptor ligands
    Husbands, SM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (12) : 1725 - 1741
  • [29] Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice
    Zhou, Yan
    Kreek, Mary Jeanne
    BRAIN RESEARCH, 2019, 1724
  • [30] Kappa opioid receptor and oligodendrocyte remyelination
    Wang, Fei
    Mei, Feng
    OPIOID HORMONES, 2019, 111 : 281 - 297
12345